Pro-inflammatory cytokines, including tumor necrosis factor α (TNFα), interleukin-6 (IL-6) and interleukin-1β (IL-1β), have shown to deteriorate normal cellular functions, leading to the metabolic diseases [3,4]. This evidence concerns the gene IL6 and metabolic disease.